Review: circulating tumor cells in the practice of breast cancer oncology, Clinical and Translational Oncology, vol.31, issue.8, pp.749-59, 2016. ,
DOI : 10.1200/JCO.2013.50.9984
The role of lymphangiogenesis and angiogenesis in tumor metastasis, Cellular Oncology, vol.13, issue.5, pp.397-410, 2016. ,
DOI : 10.1007/s11307-010-0366-1
Prognostic role of micrometastases in sentinel lymph node in patients with invasive breast cancer, International Journal of Surgery, vol.11, issue.1, pp.73-78, 2013. ,
DOI : 10.1016/S1743-9191(13)60022-9
The role of tumor lymphangiogenesis in metastatic spread, The FASEB Journal, vol.16, issue.9, pp.922-956, 2002. ,
DOI : 10.1096/fj.01-0945rev
The lymphatic vasculature in disease, Nature Medicine, vol.16, issue.11, pp.1371-80, 2011. ,
DOI : 10.1158/1535-7163.MCT-09-0554
Lymphangiogenesis and lymphatic vessel remodelling in cancer, Nature Reviews Cancer, vol.66, issue.3, pp.159-72, 2014. ,
DOI : 10.1158/0008-5472.CAN-06-2977
Retrospective preoperative assessment of the axillary lymph nodes in patients with breast cancer and literature review, Clinical Radiology, vol.70, issue.9, pp.954-963, 2015. ,
DOI : 10.1016/j.crad.2015.04.019
Tumor lymphangiogenesis and new drug development, Advanced Drug Delivery Reviews, vol.99, pp.148-60, 2016. ,
DOI : 10.1016/j.addr.2015.12.011
Lymphangiogenesis and lymphatic metastasis in breast cancer, Pathophysiology, vol.17, issue.4, pp.229-51, 2010. ,
DOI : 10.1016/j.pathophys.2009.11.003
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891887
The lymph node pre-metastatic niche, Journal of Molecular Medicine, vol.35, issue.Suppl 2, pp.1173-84, 2015. ,
DOI : 10.1016/j.biomaterials.2013.10.003
Reappraising antiangiogenic therapy for breast cancer, The Breast, vol.20, issue.3, pp.56-60, 2011. ,
DOI : 10.1016/S0960-9776(11)70295-8
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540338
Understanding the value of antiangiogenic therapy in metastatic breast cancer, Current Opinion in Oncology, vol.23, p.1, 2011. ,
DOI : 10.1097/01.cco.0000397416.67622.10
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis, Cancer Cell, vol.15, issue.3, pp.220-251, 2009. ,
DOI : 10.1016/j.ccr.2009.01.027
Antiangiogenic therapy accelerates tumor metastasis, Leukemia Research, vol.35, issue.1, pp.24-30, 2011. ,
DOI : 10.1016/j.leukres.2010.07.038
Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer, Cancer Chemotherapy and Pharmacology, vol.34, issue.11 Suppl, pp.815-839, 2016. ,
DOI : 10.3892/ijo_00000193
The Marine Fungal Metabolite, AD0157, Inhibits Angiogenesis by Targeting the Akt Signaling Pathway, Marine Drugs, vol.1802, issue.1, pp.279-99, 2014. ,
DOI : 10.1083/jcb.66.2.451
Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal, Cell Metabolism, vol.20, issue.2, pp.280-94, 2014. ,
DOI : 10.1016/j.cmet.2014.05.022
URL : http://doi.org/10.1016/j.cmet.2014.05.022
Sunitinib Inhibits Inflammatory Corneal Lymphangiogenesis, Investigative Opthalmology & Visual Science, vol.54, issue.5, pp.3082-93, 2013. ,
DOI : 10.1167/iovs.12-10856
URL : http://orbi.ulg.ac.be/bitstream/2268/151302/1/Detry%20B%202013.pdf
Additional parameters for the morphometry of angiogenesis and lymphangiogenesis in corneal flat mounts, Experimental Eye Research, vol.89, issue.2, pp.274-76, 2009. ,
DOI : 10.1016/j.exer.2009.02.021
Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway, British Journal of Pharmacology, vol.74, issue.12, pp.1966-87, 2016. ,
DOI : 10.1016/j.mvr.2007.08.006
Modeling lymphangiogenesis in a three-dimensional culture system, Nature Methods, vol.85, issue.5, pp.431-468, 2008. ,
DOI : 10.1007/BF02623576
VEGF-C Induces Lymphangiogenesis and Angiogenesis in the Rat Mesentery Culture Model, Microcirculation, vol.63, issue.6, pp.532-572, 2014. ,
DOI : 10.1002/jso.21714
Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase, Blood, vol.119, issue.21, pp.5048-56, 2012. ,
DOI : 10.1182/blood-2011-12-400267
Cell Invasion in the Spheroid Sprouting Assay: A Spatial Organisation Analysis Adaptable to Cell Behaviour, PLoS ONE, vol.85, issue.5, p.97019, 2014. ,
DOI : 10.1371/journal.pone.0097019.t003
Roles of signaling and transcriptional networks in pathological lymphangiogenesis, Advanced Drug Delivery Reviews, vol.99, pp.161-71, 2016. ,
DOI : 10.1016/j.addr.2016.01.020
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis, Nature Medicine, vol.7, issue.2, pp.192-200, 2001. ,
DOI : 10.1038/84643
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis, The EMBO Journal, vol.20, issue.4, pp.672-82, 2001. ,
DOI : 10.1093/emboj/20.4.672
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC145430
Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth, Cancer Res, vol.61, issue.5, pp.1786-90, 2001. ,
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer, British Journal of Cancer, vol.59, issue.8, pp.1154-63, 2006. ,
DOI : 10.1016/j.lfs.2003.05.006
Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer, PLoS ONE, vol.95, issue.7, p.41171, 2012. ,
DOI : 10.1371/journal.pone.0041171.s003
Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1?RAGE and AKT pathways, Biochemical and Biophysical Research Communications, vol.443, issue.4, pp.1162-1170, 2014. ,
DOI : 10.1016/j.bbrc.2013.12.064
Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling, JNCI Journal of the National Cancer Institute, vol.94, issue.11, pp.819-844, 2002. ,
DOI : 10.1093/jnci/94.11.819
Inhibition of VEGFR-3 Activation with the Antagonistic Antibody More Potently Suppresses Lymph Node and Distant Metastases than Inactivation of VEGFR-2, Cancer Research, vol.66, issue.5, pp.2650-2657, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-1843
Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase, Clinical Cancer Research, vol.14, issue.17, pp.5459-65, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-5270
The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis, Cancer Research, vol.68, issue.12, pp.4754-62, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5809
Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis, Molecular Cancer Therapeutics, vol.8, issue.1, pp.55-63, 2009. ,
DOI : 10.1158/1535-7163.MCT-08-0679
Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis, Cancer Research, vol.68, issue.19, pp.7828-7865, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-1488
Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis, Journal of Hematology & Oncology, vol.95, issue.1, p.111, 2016. ,
DOI : 10.1016/j.critrevonc.2015.02.009
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors, Journal of Hematology & Oncology, vol.92, issue.2, p.105, 2016. ,
DOI : 10.1016/j.critrevonc.2014.04.004
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study, BMC Cancer, vol.290, issue.4, p.107, 2012. ,
DOI : 10.1152/ajpheart.00133.2005
Adjuvant sunitinib in renal-cell carcinoma, N Engl J Med, vol.376, issue.9, p.893, 2017. ,
Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: A??prospective cohort study, International Journal of Surgery, vol.39, pp.30-36, 2017. ,
DOI : 10.1016/j.ijsu.2017.01.045